Literature DB >> 8632190

Allelic variation of human serotonin transporter gene expression.

A Heils1, A Teufel, S Petri, G Stöber, P Riederer, D Bengel, K P Lesch.   

Abstract

Mood, emotion, cognition, and motor functions as well as circadian and neuroendocrine rhythms, including food intake, sleep, and reproductive activity, are modulated by the midbrain raphe serotonin (5-HT) system. By directing the magnitude and duration of postsynaptic responses, carrier-facilitated 5-HT transport into and release from the presynaptic neuron are essential for the fine tuning of serotonergic neurotransmission. Interest in the mechanism of environmental factor-, disease-, and therapy-induced modification of 5-HT transporter (5-HTT) function and its impact on early brain development, event-related synaptic plasticity, and neurodegeneration is widespread and intensifying. We have recently characterized the human and murine 5-HTT genes and performed functional analyses of their 5'-flanking regulatory regions. A tandemly repeated sequence associated with the transcriptional apparatus of the human 5-HTT gene displays a complex secondary structure, represses promoter activity in nonserotonergic neuronal cells, and contains positive regulatory components. We now report a novel polymorphism of this repetitive element and provide evidence for allele-dependent differential 5-HTT promoter activity. Allelic variation in 5-HTT-related functions may play a role in the expression and modulation of complex traits and behavior.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632190     DOI: 10.1046/j.1471-4159.1996.66062621.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  554 in total

Review 1.  The challenges of psychopharmacogenetics.

Authors:  M Catalano
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Role of pharmacogenomics in individualising treatment with SSRIs.

Authors:  Dalu Mancama; Robert W Kerwin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 3.  The heritability of postpartum depression.

Authors:  Elizabeth J Corwin; Ruth Kohen; Monica Jarrett; Brian Stafford
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

4.  Serotonin transporter promoter region (5-HTTLPR) polymorphism predicts resting respiratory sinus arrhythmia.

Authors:  Alissa J Ellis; Christopher G Beevers; J Gregory Hixon; John E McGeary
Journal:  Psychophysiology       Date:  2010-11-23       Impact factor: 4.016

5.  Building conditions, 5-HTTLPR genotype, and depressive symptoms in adolescent males and females.

Authors:  Monica Uddin; Regina de los Santos; Erin Bakshis; Caroline Cheng; Allison E Aiello
Journal:  J Adolesc Health       Date:  2011-05-20       Impact factor: 5.012

6.  Sex-specific pathways among tri-allelic serotonin transporter polymorphism, trait neuroticism and generalized anxiety disorder.

Authors:  Hsin-An Chang; Wen-Hui Fang; Yia-Ping Liu; Nian-Sheng Tzeng; Jia-Fwu Shyu; Fang-Jung Wan; San-Yuan Huang; Tieh-Ching Chang; Chuan-Chia Chang
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

7.  Is there an optimum endurance polygenic profile?

Authors:  Jonatan R Ruiz; Félix Gómez-Gallego; Catalina Santiago; Marta González-Freire; Zoraida Verde; Carl Foster; Alejandro Lucia
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

8.  Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease.

Authors:  John P Capitanio; Kristina Abel; Sally P Mendoza; Shelley A Blozis; Michael B McChesney; Steve W Cole; William A Mason
Journal:  Brain Behav Immun       Date:  2007-08-23       Impact factor: 7.217

9.  Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.

Authors:  George A Kenna; William H Zywiak; Robert M Swift; John E McGeary; James S Clifford; Jessica R Shoaff; Cynthia Vuittonet; Samuel Fricchione; Michael Brickley; Kayla Beaucage; Carolina L Haass-Koffler; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

Review 10.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.